Our goal is to further expand our position as global market leader in an agilely changing global market environment and lead our industry as the preferred partner for customers and suppliers.

We strive to extend our market leadership through sustainable organic growth and by continuously and systematically increasing profitability.

At the beginning of 2020, we launched “Project Brenntag” with a view to laying strong foundations for future organic earnings growth. Through this broad transformation programme, we aim to adopt a more focused approach to our market activities, build stronger partnerships with our customers and suppliers, and reduce complexity. The core elements are the new operating model comprising two global segments with a strong focus on customer and supplier requirements, a distinct go-to-market approach derived from that, (infra-)structural topics as well as supporting people and change management measures.

In addition, we continue to seek acquisition opportunities that support our strategy. Our strategic focus here is on expanding our presence in emerging markets in Asia Pacific in particular so as to capture the expected strong growth in demand for chemicals and ingredients in these regions. In the established markets of Western Europe and North America, our acquisition strategy focuses on steadily optimizing our product and service portfolio.

Our people measures are centred on extensive employee skills enhancement and personal growth in alignment with the company’s transformation and on targeted succession planning. Through “Project Brenntag”, we will promote global collaboration, establish a new management culture, and enable our employees to take on new roles. We will best position the Brenntag brand in the employment market so as to recruit and retain highly qualified employees.

“We are entering new technologies with a focus on some key areas such as oncology, where we are continuing to bring new generics to the Turkish market. We have developed a focus on ophthalmology as well, where we are very strong and have launched a generic in dry eye treatment in the Turkish market and a new product that promises double the strength and is therefore unique in Turkey.”